Drug Profile
Pegarginase - Enzon Pharmaceuticals
Alternative Names: Arginase macrogol; PEG-arginase - Enzon Pharmaceuticals; Polyethylene glycol arginaseLatest Information Update: 29 Apr 2011
Price :
$50
*
At a glance
- Originator Enzon Pharmaceuticals
- Class Antineoplastics; Polyethylene glycols; Ureohydrolases
- Mechanism of Action Arginase replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 08 Sep 1998 Profile reviewed
- 08 Sep 1998 No-Development-Reported for Cancer in USA (Unknown route)
- 22 Aug 1996 Preclinical development for Cancer in USA (Unknown route)